ExLibris header image
SFX Logo
Title: Altered expression of SIRPγ on the T-cells of relapsing remitting multiple sclerosis and type 1 diabetes patients could potentiate effector responses from T-cells
Source:

Plos One [1932-6203] Sinha, Sushmita yr:2020


Collapse list of basic services Basic
Full text
Full text available via PubMed Central
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Ataide, Marco A. "BATF3 programs CD8+ T cell memory." Nature Immunology 21.11 (2020): 1397-1407. Link to SFX for this item
2. Dammeijer, F. "The PD-1/PD-L1-Checkpoint Restrains T cell Immunity in Tumor-Draining Lymph Nodes." Cancer Cell 38.5 (2020): 685-4294967295. Link to SFX for this item
3. Marangoni, F. "Expansion of tumor-associated Treg cells upon disruption of a CTLA-4-dependent feedback loop." Cell. 184.15: 3998-4294967295. Link to SFX for this item
4. Xia, J. "Galectin-3 favours tumour metastasis via the activation of β-catenin signalling in hepatocellular carcinoma." British Journal of Cancer (2020). Link to Full Text for this item Link to SFX for this item
5. Raeber, Miro E. "Interleukin-2 signals converge in a lymphoid-dendritic cell pathway that promotes anticancer immunity." Science Translational Medicine 12.561 (2020). Link to SFX for this item
6. Beltra, J. "Developmental Relationships of Four Exhausted CD8+ T Cell Subsets Reveals Underlying Transcriptional and Epigenetic Landscape Control Mechanisms." Immunity 52.5 (2020): 825-4294967295. Link to SFX for this item
7. O'Gorman, Thomas D. "Peripheral T cell expansion predicts tumour infiltration and clinical response." Nature 579.7798 (2020): 274-278. Link to Full Text for this item Link to SFX for this item
Select All Clear All

Expand list of advanced services Advanced